Market Overview

Meningioma | A Drug Pipeline Analysis Report 2018 | Technavio

Share:

Technavio has announced their latest drug pipeline analysis report on meningioma.
The report includes a detailed analysis of the pipeline molecules under
investigation within the defined data collection period to treat
Meningioma.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180727005542/en/

Technavio has published a new report on the drug development pipeline for meningioma, including a de ...

Technavio has published a new report on the drug development pipeline for meningioma, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Meningioma: Market overview

Meningioma is a tumor that arises from the meninges, membranes that
surround the brain and spinal cord. Although it is not exactly a brain
tumor, it is included in this category because it may compress or
squeeze the adjacent brain tissue, nerves, and vessels. It is the most
common type of tumor that forms in the head. Most meningiomas grow very
slowly, often over many years, without causing symptoms. But in some
cases, their effects on adjacent brain tissue, nerves or vessels may
cause serious consequence. Since most of the meningiomas grow slowly,
they do not always require immediate treatment and can be monitored over
time.

According to a senior market research analyst at Technavio, "A surge
in the incidence of the primary brain tumors in general and of
meningiomas specifically has been registered in many countries during
the past decades. It is said that the main reason for this surge could
be the aging population, better access to advanced healthcare
facilities, and diagnostic procedures, and the changes in coding
classification for the meningiomas registered."

Meningioma: Segmentation analysis

This pipeline analysis report segments the meningioma market based on
RoA (oral, intravenous, and intramuscular), targets (PD-1, CDK4 and
CDK6, mTORC1/mTORC2, MEK1/MEK2, RTK, NMDA receptor, PP2A, DNA, PDL1, and
somatostatin receptor), geographical segmentation (the US, Austria,
Spain, France, Italy, and Belgium) and recruitment status (active, not
recruiting, completed, not yet recruiting, and recruiting). It provides
an in-depth analysis of the prominent factors influencing the market,
including drivers, opportunities, trends, and industry-specific
challenges.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!